profile ...
subline 1
subline 2
subline 3
subline 4
subline 5
subline 6
resources ...
subline 1
subline 2
subline 3
subline 4
subline 5
subline 6
mission statement ...
subline 1
subline 2
subline 3
subline 4
subline 5
subline 6
technologies ...
subline 1
subline 2
subline 3
subline 4
subline 5
subline 6
press ...
subline 1
subline 2
subline 3
subline 4
subline 5
subline 6
QMS ...
subline 1
subline 2
subline 3
subline 4
subline 5
subline 6
product lines ...
subline 1
subline 2
subline 3
subline 4
subline 5
subline 6
applications ...
subline 1
subline 2
subline 3
subline 4
subline 5
subline 6
services ...
subline 1
subline 2
subline 3
subline 4
subline 5
subline 6
market ...
subline 1
subline 2
subline 3
subline 4
subline 5
subline 6
usp's ...
subline 1
subline 2
subline 3
subline 4
subline 5
subline 6
address ...
subline 1
subline 2
subline 3
subline 4
subline 5
subline 6
find us ...
subline 1
subline 2
subline 3
subline 4
subline 5
subline 6
3D tour ...
subline 1
subline 2
subline 3
subline 4
subline 5
subline 6
 
 
     

Capacities

Production
* Bioreactors
* Pump and control systems

Cell Biology
* Isolation of primary cells from human organs
* Cell culture
* Cell regeneration after preservation injury
* Cell expansion

Service
* Stand-by service of clinical systems with cultured cells
* Logistics for clinical application

Test Laboratory
A physicotechnical laboratory for the application of bioreactors and control systems is available for:
* Quality control production
* Long-term testing
* Testing of custom made special manufacture
* Development/testing of prototypes
* Development/testing of procedures
* Development/testing of fittings
* Quality control/trouble shooting

Research & Development
Hybrid Organ’s R&D and clinical studies capacities are significantly supported by the company’s cooperation agreements with the Charité, Medical Faculty of Berlin's Humboldt University, its Transplantation Center at the Campus Virchow Clinic, the Division of Experimental Surgery of the Surgical Department and the Charité Institute for Transplantation and Organ Replacement (CITO).

Hybrid Organ has created an R&D management system for design control procedures, R&D studies and documentation according to international standards (ISO 9001 ff.).While Hybrid Organ enables strategic industrial R&D for product development, fundamental research is also possible within the university cooperation. Research operations are conducted at the Biomedical Research Center of the Charité, which provides multi-user equipment for electron microscopy, mechanical laboratory, metal and plastic work, electronic laboratories, microbiology, biochemistry, molecular biology and histology. The ultimate goal of Hybrid Organ’s fundamental research program is the development of new medical therapies with bioreactors and hybrid organs.

Hybrid Organ’s core competencies are completed by a number strategic R&D co-operations. In the field of chemical engineering techniques and cell systems, Hybrid Organ is working together with the University of Bielefeld (Biotechnology) and in the field of process engineering and reactor systems with the Technical University of Berlin (Bio Process Engineering). The company also collaborates with another Berlin-based company, Biochrom KG, which specializes in GMP media cultures

 
profile
mission statement
patents
capacities
technologies
management
publications
 
 
 
product lines
applications
logistic system
MELS animation
services
QMS
market
usp's
address
find us
3D tour
imprint